ADARx Pharmaceuticals, Inc. (ADRX) income statement
ADRXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Last filing: 10-Q on Nov 12, 2026
$12.79−1.37 (-9.68%)
Close on Nov 20, 2026Market cap $1.37BP/E –Yield –
ADARx Pharmaceuticals, Inc. financial ratios
Not enough reported data yet to compute ratios by period.
See a number that looks wrong?